Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$3.17 - $7.91 $29,008 - $72,384
-9,151 Reduced 12.52%
63,939 $217,000
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.21 $261,549 - $470,077
35,585 Added 94.88%
73,090 $537,000
Q1 2023

May 10, 2023

SELL
$7.79 - $16.29 $2,188 - $4,577
-281 Reduced 0.74%
37,505 $388,000
Q4 2022

Feb 13, 2023

SELL
$11.0 - $21.45 $15,950 - $31,102
-1,450 Reduced 3.7%
37,786 $446,000
Q3 2022

Nov 10, 2022

SELL
$20.09 - $35.8 $111,941 - $199,477
-5,572 Reduced 12.44%
39,236 $824,000
Q2 2022

Aug 12, 2022

SELL
$27.42 - $43.63 $140,692 - $223,865
-5,131 Reduced 10.27%
44,808 $1.39 Million
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $42,061 - $60,209
1,153 Added 2.36%
49,939 $2.05 Million
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $9,535 - $15,842
-288 Reduced 0.59%
48,786 $2.12 Million
Q3 2021

Nov 12, 2021

BUY
$50.07 - $66.05 $278,939 - $367,964
5,571 Added 12.81%
49,074 $2.46 Million
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $133,599 - $189,885
-2,360 Reduced 5.15%
43,503 $2.78 Million
Q1 2021

May 14, 2021

SELL
$86.23 - $125.19 $2.71 Million - $3.93 Million
-31,405 Reduced 40.64%
45,863 $4.26 Million
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $1.61 Million - $2.27 Million
20,323 Added 35.69%
77,268 $6.92 Million
Q3 2020

Nov 13, 2020

SELL
$81.91 - $134.94 $1.19 Million - $1.96 Million
-14,527 Reduced 20.33%
56,945 $5.88 Million
Q2 2020

Aug 12, 2020

BUY
$54.33 - $89.52 $770,616 - $1.27 Million
14,184 Added 24.76%
71,472 $5.65 Million
Q1 2020

May 13, 2020

SELL
$49.34 - $68.76 $462,759 - $644,900
-9,379 Reduced 14.07%
57,288 $3.31 Million
Q4 2019

Feb 12, 2020

BUY
$51.21 - $59.06 $1.74 Million - $2.01 Million
34,029 Added 104.26%
66,667 $3.6 Million
Q3 2019

Nov 12, 2019

BUY
$40.6 - $57.2 $134,142 - $188,988
3,304 Added 11.26%
32,638 $1.71 Million
Q2 2019

Aug 14, 2019

SELL
$39.92 - $53.86 $883,389 - $1.19 Million
-22,129 Reduced 43.0%
29,334 $1.42 Million
Q1 2019

May 14, 2019

SELL
$48.23 - $66.16 $1.17 Million - $1.6 Million
-24,235 Reduced 32.02%
51,463 $2.6 Million
Q4 2018

Feb 13, 2019

BUY
$55.63 - $73.24 $2.31 Million - $3.04 Million
41,545 Added 121.64%
75,698 $4.49 Million
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $667,541 - $852,990
-12,825 Reduced 27.3%
34,153 $2.25 Million
Q2 2018

Aug 14, 2018

BUY
$48.33 - $55.64 $614,515 - $707,462
12,715 Added 37.11%
46,978 $2.37 Million
Q1 2018

May 15, 2018

BUY
$44.44 - $54.39 $182,159 - $222,944
4,099 Added 13.59%
34,263 $1.8 Million
Q4 2017

Feb 14, 2018

SELL
$37.77 - $47.75 $510,537 - $645,436
-13,517 Reduced 30.94%
30,164 $1.4 Million
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $470,722 - $557,724
13,788 Added 46.12%
43,681 $1.77 Million
Q2 2017

Aug 14, 2017

BUY
N/A
29,893
29,893 $1.01 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.